Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.
Infect Immun
; 14(1): 318-9, 1976 Jul.
Article
em En
| MEDLINE
| ID: mdl-820645
ABSTRACT
Stabilization of polyriboinosinic-polyribocytidylic acid against enzymatic hydrolysis by addition of poly-1-lysine and carboxymethylcellulose (PICLC) resulted in a compound with marked adjuvanticity. The primary antibody response of rhesus monkeys to formalin-inactivated Venezuelan equine encephalomyelitis virus vaccine was significantly potentiated if the vaccine was combined with PICLC prior to vaccination. The antibody response was maintained at a significantly higher level than controls for 2.5 months postvaccination and paralleled immunological responses reported for live, attenuated (TC-83) vaccine.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas Atenuadas
/
Vacinas Virais
/
Adjuvantes Imunológicos
/
Poli I-C
/
Vírus da Encefalite Equina Venezuelana
/
Formação de Anticorpos
Limite:
Animals
Idioma:
En
Revista:
Infect Immun
Ano de publicação:
1976
Tipo de documento:
Article
País de publicação:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA